| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | -9.7% |
| Cost of Revenue | $1.6M | -29.5% |
| Gross Profit | $959K | +71.2% |
| R&D Expense | $6.4M | -16.8% |
| SG&A Expense | $6.8M | -48.8% |
| Operating Income | -$29.5M | -14.6% |
| Interest Expense | $631K | +123.0% |
| Pre-tax Income | -$30.0M | -20.1% |
| Income Tax | $0 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.7M | +30.0% |
| Accounts Receivable | $582K | -62.1% |
| Current Assets | $5.7M | -11.0% |
| Total Assets | $30.2M | +6.0% |
| Current Liabilities | $29.6M | +238.7% |
| Long-term Debt | $7.4M | +17.0% |
| Total Liabilities | $37.0M | +145.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.2M | +36.8% |
| Capital Expenditures | $262K | -95.8% |
| Investing Cash Flow | -$262K | -106.9% |
| Financing Cash Flow | $15.6M | — |
| Free Cash Flow | -$14.5M | +49.5% |
| — |
| Net Income | -$30.0M | -20.1% |
| EPS (Basic) | -$0.77 | -10.0% |
| EPS (Diluted) | -$0.77 | -10.0% |
| Stockholders' Equity |
| -$6.8M |
| -150.3% |